98%
921
2 minutes
20
Background: Mutations in the fibrillin-1 gene (FBN1) are associated with various heritable connective tissue disorders (HCTD). The most studied HCTD is Marfan syndrome. Ninety percent of Marfan syndrome is caused by mutations in the FBN1 gene. The zebrafish share high genetic similarity to humans, representing an ideal model for genetic research of human diseases. This study aimed to generate and characterize fbn1 mutant zebrafish using the CRISPR/Cas9 gene-editing technology.
Methods: CRISPR/Cas9 was applied to generate an fbn1 frameshift mutation (fbn1 ) in zebrafish. F1 fbn1 heterozygotes were crossed with transgenic fluorescent zebrafish to obtain F2 fbn1 zebrafish. Morphological abnormalities were assessed in F2 fbn1 zebrafish by comparing with the Tuebingen (TU) wild-type controls at different development stages.
Results: We successfully generated a transgenic line of fbn1 zebrafish. Compared with TU wild-type zebrafish, F2 fbn1 zebrafish exhibited noticeably decreased pigmentation, increased lengths, slender body shape, and abnormal cardiac blood flow from atrium to ventricle.
Conclusion: We generated the first fbn1 zebrafish model using CRISPR/Cas9 gene-editing approach to mimic FBN1 genetic defects in humans, providing an attractive model of Marfan syndrome and a method to determine the pathogenicity of gene mutation sites.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580104 | PMC |
http://dx.doi.org/10.1002/mgg3.1775 | DOI Listing |
J Med Genet
June 2025
Departments of Neurology and Pediatrics, Washington University School of Medicine in St Louis, St Louis, Missouri, USA
Background: Scoliosis is the most common paediatric spinal deformity. More than 80% of scoliosis is idiopathic and appears during the adolescent growth spurt. Spinal fusion surgery is often required for patients with progressive adolescent idiopathic scoliosis (AIS), and the genetic risk factors for severe disease (defined here as curve >35 degrees) are largely unknown.
View Article and Find Full Text PDFBMC Genomics
March 2025
Department of Cardiac Surgical Intensive Care Unit, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Background: Marfan syndrome (MFS) is an inherited autosomal dominant disorder that affects connective tissue with an incidence of about 1 in 5,000 to 10,000 people. 90% of MFS is caused by mutations in the fibrillin-1 (FBN1) gene. We recruited a family with MFS phenotype in South China and identified a novel variant.
View Article and Find Full Text PDFFront Genet
January 2025
Sichuan Provincial Key Laboratory for Genetic Disease, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Marfan syndrome (MFS) is an inherited disorder that affects the connective tissues and mainly presents in the bones, eyes, and cardiovascular system, etc. Aortic pathology is the leading cause of death in patients with Marfan syndrome. The fibrillin-1 gene () is a major gene involved in the pathogenesis of MFS.
View Article and Find Full Text PDFGenetics
January 2024
Mater Research Institute-University of Queensland, Translational Research Institute, Woolloongabba QLD 4102, Australia.
The fibrillinopathies represent a group of diseases in which the 10-12 nm extracellular microfibrils are disrupted by genetic variants in one of the genes encoding fibrillin molecules, large glycoproteins of the extracellular matrix. The best-known fibrillinopathy is Marfan syndrome, an autosomal dominant condition affecting the cardiovascular, ocular, skeletal, and other systems, with a prevalence of around 1 in 3,000 across all ethnic groups. It is caused by variants of the FBN1 gene, encoding fibrillin-1, which interacts with elastin to provide strength and elasticity to connective tissues.
View Article and Find Full Text PDFTransl Vis Sci Technol
March 2022
Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands.